SCHEMBL326698

SCHEMBL326698

CCN(C=C(C)C(=O)O)CC

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.32
AKR1C3 P42330 1/20 0.32
FFAR3 O14843 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676068 1.00 PTGS1 (0.32) PTGS1AKR1C3FFAR3ALDH1A1TDP1
Ammonia Solution, Strong SCHEMBL5462340 0.98 PTGS1 (0.31) PTGS1AKR1C3
Ethyl Chloride SCHEMBL27602561 0.93
Methacrylic Acid SCHEMBL7114431 0.91
Bromide SCHEMBL28732726 0.82
Hydrochloric Acid SCHEMBL28732718 0.82
SCHEMBL3285603 0.81 CA12 (0.33) PTGS1AKR1C3
SCHEMBL3285600 0.81 CA12 (0.33) PTGS1AKR1C3
SCHEMBL8142312 0.80 GLO1 (0.37) ALDH1A1
SCHEMBL554563 0.78 TDP1 (0.32) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3890685-B1 COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE ENCAPSYS LLC (US) 2026-03-11 EP claimed
US-12312566-B2 Compositions comprising benefit agent containing delivery particle ENCAPSYS, LLC (US) 2025-05-27 US claimed
US-12146124-B2 Benefit-agent-containing delivery particles having high core to wall ratios ENCAPSYS, LLC (US) 2024-11-19 US claimed
CN-112638352-B Composition comprising benefit agent-containing delivery particles 恩盖普有限公司 2024-05-07 CN claimed
CN-113164789-B Composition comprising an encapsulate 宝洁公司 2024-01-09 CN claimed
EP-4247895-A1 POLY ACRYLATE AND POLY(BETA-ESTER) CAPSULES WITH ENHANCED DEGRADABILITY Encapsys, LLC (US) 2023-09-27 EP claimed
CN-116472303-A Polyacrylate and poly (beta-ester) capsules with improved degradability 恩盖普有限公司 2023-07-21 CN claimed
CN-112358583-B High-molecular surfactant capable of reducing irritation of AES (ethylene diamine tetraacetic acid) and preparation method of high-molecular surfactant 广东灵捷制造化工有限公司 2022-10-21 CN claimed
CN-115135307-A Carrier for cell delivery 株式会社ITO 2022-09-30 CN claimed
CN-114806597-A Liquid crystal composition, liquid crystal handwriting film and liquid crystal handwriting board 深圳市小柔科技有限公司 2022-07-29 CN claimed
EP-0752625-B1 Copolymers useful as charge injection barrier materials for photoreceptor HEWLETT PACKARD CO (US) 2000-11-15 EP claimed
WO-2000065352-A1 POLYIONIC COATINGS IN ANALYTIC AND SENSOR DEVICES EIDGENOSSISCH TECHNISCHE HOCHSCHULE ZURICH (CH) 2000-11-02 WO claimed
EP-0975691-A1 MULTIFUNCTIONAL POLYMERIC TISSUE COATINGS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-02-02 EP claimed
WO-1998047948-A1 MULTIFUNCTIONAL POLYMERIC TISSUE COATINGS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-10-29 WO claimed
US-5777068-A Photosensitive polyimide resin composition NIPPON ZEON CO., LTD. (JP) 1998-07-07 US claimed
US-5705247-A UV CURED PROTECTIVE LAYER, ADHERED HYDROPHILIC RESIN PRINTING LAYER TAIYU YUDEN CO., LTD. (JP) 1998-01-06 US claimed
EP-0752625-A2 Copolymers useful as charge injection barrier materials for photoreceptor Hewlett-Packard Company (US) 1997-01-08 EP claimed
EP-0628956-A1 Optical information medium and method for fabricating same TAIYO YUDEN CO., LTD. (JP) 1994-12-14 EP claimed
EP-0252739-B1 ADHESIVE SHEETS FOR STICKING WAFERS THERETO LINTEC Corporation (JP) 1993-10-06 EP claimed
US-4209398-A ANTISCALING AND ANTIDEPOSIT AGENTS; ACRYLIC POLYMERS, PHOSPHORUS COMPOUNDS, METAL SALTS KURITA WATER INDUSTRIES LTD. (JP) 1980-06-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12312566-B2 Compositions comprising benefit agent containing delivery particle APOB, CHMP4B, HDLBP PTGS1 3178/4885AKR1C3 4019/4885FFAR3 3642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.